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The binding of labeled phosphatidylserine (PS) to a collection of synthetic 15-mer peptides covering full-length glycoprotein
G (G) of viral hemorrhagic septicemia virus (VHSV), a salmonid rhabdovirus, showed three dominant overlapping reactive
peptides. This major PS-binding region was contained in a 28-mer peptide (p2; aa 82–109) with consecutive hydrophobic
amino acid a–d heptad repeats (putative amphipathic a-helix) and 2 carboxy-terminal arginines. This 28-mer peptide showed
a 10-fold higher apparent specific activity for PS binding than the 15-mer peptides. Binding to PS was also detected with
virion-purified protein G but was not detected with other viral proteins. The highest apparent specific activity for PS binding
was found with purified VHSV particles by both solid-phase and liquid assays. In contrast to the pH-independent PS binding
to peptide p2, binding to virions was optimal at pH 5.6. PS binding to purified VHSV was greatly reduced by protease or
detergent treatments that removed protein G, by treatment at pH 7.6, or by anti-p2 mouse antibodies at pH 5.6. The PS-
binding region seems to be related to viral–host cell fusion since anti-p2 mouse antibodies inhibited VHSV-infected cell to
cell fusion (fusion from within) and the pH profile of the VHSV-infected cell to cell fusion was similar to the pH profile of
PS binding to VHSV. Comparative analysis showed that sequences similar to the major PS-binding domain of VHSV were
also present in other fish rhabdoviruses and in rabies and vesicular stomatitis viruses. q 1996 Academic Press, Inc.
INTRODUCTION the protein is implicated in the interaction with the host
phospholipids (Gaudin et al., 1995).
The homotrimeric glycoprotein G (G) of both mamma-
On the other hand, exposure of isolated rabies G tri-lian (Gaudin et al., 1993, 1992) and fish (Lecocq-Xhon-
mers to low pH is known to induce conformational andneux et al., 1994; Coll, 1995a) rhabdoviruses is responsi-
size changes (Gaudin et al., 1993) that expose hydropho-ble for its attachment to the receptor of the host cellular
bic inner regions to its surface (Bourhy et al., 1993), simi-membranes and for its subsequent low-pH (5.5)-depen-
lar to findings on the fusion peptide of the influenza virusdent membrane fusion activity (Rigaut et al., 1991;
(Bullough et al., 1994; Carr and Kim, 1993). Also, theSchlegel et al., 1982; Superti et al., 1984). Most probably
mapping of fusion-defective VSV mutants by insertionthe receptor-binding site and the so-called fusion peptide
and site-directed mutagenesis have shown that although(and/or its surrounding sequences) would not be in the
several regions distributed through the G molecule seemsame envelope protein region as they are in influenza
to alter fusion (Li et al., 1993; Whitt et al., 1990), mutations(Bizebard et al., 1995; Bullough et al., 1994; Carr and
in the region from amino acid (aa) 123–137 could varyKim, 1993) or in tick-borne encephalitis (Rey et al., 1995)
the optimum pH for fusion and were thus proposed for aviruses, the only viral membrane proteins for which X-ray
putative internal fusion peptide (Zhang and Ghosh, 1994).structure has been solved to date. However, the nature
Furthermore, the above-mentioned region (aa 58–221 forof the rhabdovirus receptor(s) is not yet clear, although
VSV and aa 102–179 for rabies virus) was labeled byprevious studies have implicated host phospholipid bind-
hydrophobic photolabeling techniques under conditionsing as being important for the entry of rhabdoviruses into
favoring fusion (Gaudin et al., 1995).the cells they infect. Thus, phospholipids extracted from
Because the lack of a vaccine against fish rhabdovi-cellular membranes inhibited attachment and infection
ruses makes these the most damaging diseases of theof rabies virus (Superti et al., 1984) and of vesicular sto-
international salmoniculture industry and of wild watersmatitis virus (VSV) (Bailey et al., 1984; Conti et al., 1988;
(Lorenzo et al., 1995; Estepa et al., 1994; Leong and Fryer,Mastromarino et al., 1987; Schlegel et al., 1982), and
1993; Lorenzen et al., 1993), the study of fish rhabdovi-phosphatidylserine (PS) was the strongest inhibitor of
rus–cellular membrane interactions could be of impor-VSV attachment at physiological pH (Schlegel et al.,
tance in the design of alternative methods to fight these1983). Moreover, it is not yet known which region of
diseases. In the present study, we have characterized in
detail the PS binding to the G protein of a fish rhabdovi-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 34-1-620 22 47. rus. This study focuses on the viral hemorrhagic septice-
600042-6822/96 $12.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
/ m4950$7664 01-12-96 08:09:41 vira AP-Virology
61PHOSPHATIDYL-BINDING DOMAIN OF VHSV GLYCOPROTEIN
mia virus, VHSV (a fish rhabdovirus exhibiting G-medi- ml/well at a final concentration about 3000 pmol/well.
Protein G peptides p2 (aa 82–109), p3 (aa 110–121), andated low-pH-dependent fusion) (Lecocq-Xhonneux et al.,
1994), and demonstrate, using synthetic peptides in p4 (aa 122–151) were from Clontech (Palo Alto, CA).
Irrelevant peptides were pA (TWKEYNHNLQLDDGTC)solid-phase assays, that the major PS-binding region
maps to aa residues80–110 of the G protein. Synthetic and pB (PYRRDCVTTTVENED).
peptides from this region bound PS and antibodies
Analysis of the protein G of rhabdovirusesagainst the dominant peptide inhibited both PS binding to
VHSV and virus-induced cell to cell fusion. Comparative
The cDNA-derived G sequences of VHSV (Lorenzen et
sequence studies showed that all other rhabdovirus G
al., 1993; Thiry et al., 1991) and of other rhabdoviruses
proteins analyzed have a similar predicted phospholipid
were studied with the ANTIGEN program from PCGene
binding domain that probably adopts an amphipathic a-
(Intelligenetics, Geneva, Switzerland). DG values ⁄0.4
helical structure.
kcal/mol to transfer the aa sidechain from water to etha-
nol (Schulz and Schimer, 1984) defined the hydrophobic
MATERIALS AND METHODS aa (F, Y, I, L, V, M, A / W, H, T) that were used to search
for heptad-repeat sequences with the possibility of form-Purification of VHSV
ing amphipathic helices (hydrophobic aa in a and d posi-
The VHSV 07.71 isolated in France (LeBerre et al., tions) with the program PSEARCH. The subsequence
1977) from rainbow trout Onchorynchus mykiss (Wal- searched was (hydrophobic aa)XX(hydrophobic aa)XXX
baum) was grown and/or assayed for infectivity in epithe- (X for any aa). The hydrophobic aa sequences of the
lial papillosum cyprine (EPC) cells. VHSV concentrated predicted transmembrane and signal peptide regions
by ultracentrifugation or by polyethyleneglycol precipita- were not considered (Coll, 1995b). Coiled coils (a–d posi-
tion was layered on a 15 to 45% sucrose gradient in TNE tions of heptad repeats mainly occupied by aa F, Y, I, L,
(0.15 M Tris, 0.15 M NaCl, 1 mM EDTA, pH 7.6) and spun V, M, and A) were searched with the program COIL (Lu-
at 80,000 g for 270 min in a Beckman ultracentrifuge. pas et al., 1991).
The material banding at 31% sucrose contained the viral
infectivity, whole virions, by electron microscopy, and all Preparation of anti-p2 mouse antibodies
the viral proteins (purified VHSV). The material banding
Female BALB/c mice were injected with 20 mg of p2at 26% sucrose contained traces of viral infectivity, nu-
peptide in Freund’s complete adjuvant and then fourcleocapsids, and the N and Nx viral proteins (Basurco
monthly injections in Freund’s incomplete adjuvant wereand Coll, 1992). These fractions were further purified by
carried out. To obtain about 40 ml of pooled diluted asci-ultracentrifugation over a 20% sucrose cushion.
tes containing antibodies, three p2-immunized mice werePurified VHSV was treated with 1% Triton X-100, Tween
each intraperitoneally injected with 0.5–2 1 106 viable20, or CHAPS during 30 min at 207 and the G-free virions
myeloma X63/Ag8653 cells (Coll, 1989). The anti-p2 waswere isolated by ultracentrifugation over a 20% sucrose
purified from ascitic fluid by chromatography over a p2-cushion at 80,000 g for 3 hr (Gaudin et al., 1992). Purified
activated CH–Sepharose-4B column (Sigma ChemicalVHSV (200 mg/100 ml) were treated with 1 mg/ml trypsin
Co., St. Louis, MO) with an 8-atom spacer. Specific anti-or V8 protease at 377, pH 7.6, during 2 hr to digest the
bodies were eluted with ethylenediamine, pH 12.5, neu-G. To label VHSV a [U-14C]aa lysate (Amersham, Bucking-
tralized, dialyzed, lyophilized, and reconstituted in phos-hamshire, England) was added during the VHSV infection
phate-buffered saline, pH 7.4.at 4 mCi/ml. The number of G molecules per virion (300
pmol of G/200 mg of VHSV) was calculated from densi-
Purification of viral proteins
tometry valves of the autoradiograph of purified labeled
VHSV separated by polyacrylamide gel electrophoresis The G, N, M1, and M2 proteins were isolated in dena-
(PAGE). tured form by preparative PAGE of purified VHSV in the
presence of SDS and b-mercaptoethanol (Estepa et al.,
Synthetic peptides from the G sequence of VHSV 1991). Soluble G protein (Gs) was isolated by affinity
chromatography over Sepharose–concanavalin A from
Synthesis of 15-mer peptides overlapping 5 aa and
VHSV-infected VHSV-free cell culture supernatants (Ruiz-
spanning the cDNA-derived aa sequence of G protein
Gonzalvo and Coll, 1993). The Gs contained 30% of the
(Thiry et al., 1991) of VHSV 07.71 was performed (Chiron
molecules as trimers as shown by ultracentrifugation and
Mimotopes, Victoria, Australia). The peptides were
70% as monomers of 60 kDa as shown by PAGE.
named by a number corresponding to the position of
their middle aa (8th position) in the G, the first peptide Solid-phase phospholipid binding assays
being the p6, due to synthesis requirements (it contained
2 additional aa before the initial methionine). The pep- The labeled phospholipids, 53–55 mCi/mmol, L-3-
phosphatidyl-[L-C3-14C]serine, 1,2-dioleoyl (PS); L-3-tides diluted in 5 mM HEPES, pH 7, were dried in 100
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phosphatidylcholine, 1-palmitoyl-2-[1-14C]linoleoyl (PC); mg/well of anti-p2 antibodies in phosphate/citrate buffer
containing 0.5% albumin at pH 5.6. Detection of theor L-3-phosphatidylethanolamine, 1-palmitoyl-2-[1-14C]-
linoleoyl (PE) (Amersham, Buckinghamshire, England) amount of anti-p2 bound and color development was
carried out with rabbit anti-mouse immunoglobulins con-were dissolved in organic solvents and dried in glass
tubes. Once resuspended in phosphate/citrate buffer jugated to peroxidase and o-phenylenediamine (Sanz
and Coll, 1992).(Gaudin et al., 1993) the mixture was sonicated at 47 for
three 1-min periods to a size of 20 1 103 kDa as esti-
mated by chromatography over Sepharose 4B (manu-
Neutralization/immunoperoxidase assay
script in preparation). Samples of 100 ml/well of viruses,
viral proteins, or peptides were dried at 377 in 96-well About 103 TCID50 per milliliter of VHSV 07.71 was incu-
plates (polystyrene from Costar/Nunc). Just prior to use, bated overnight at 47 with serial dilutions of anti-VHSV
the coated plates were washed and 100 ml/well of la- antibodies in 100 ml as described (Lorenzo et al., 1995).
beled phospholipids in phosphate/citrate buffer was Mixtures of virus/antibody were added to EPC mono-
added. After 4 hr of incubation at 47, the plates were layers in 96-well plates. After an adsorption time of 2 hr
washed three times with distilled water and incubated at 47, the plates were washed and 100 ml/well of RPMI-
with 100 ml/well of 2% SDS, 50 mM ethylenediamine, pH 1640, 2% fetal calf serum, and 20 mM HEPES was added.
12.5, at 507 during 30 min. The extracts were transferred After an overnight incubation at 147, the cultures were
to 96-well polyethylene terephthalate plates (Wallac – fixed for 10 min in cold methanol and dried. To detect
Pharmacia), 100 ml of Hiload scintillation liquid (LKB, the N antigen of VHSV, the MAb 2C9 diluted 1000-fold
Loughtrough, England) was added per well, and they in dilution buffer (130 mM NaCl, 2 mM KCl, 8 mM
were mixed and counted on a 1450 Microbeta scintilla- Na2HPO4 , 1.4 mM KH2PO4 , 0.24 mM merthiolate, 5 g of
tion counter (Wallac, Turku, Finland, and Pharmacia Iber- Tween 20/liter, 50 mg of phenol red/liter, pH 6.8) was
ica). Backgrounds (maximum of 0.5 pmol of PS/well) were added to the wells (100 ml/well) for 1 hr. Detection of
estimated by PS binding to empty polystyrene wells. The the bound 2C9 was done with peroxidase-labeled anti-
apparent PS binding was expressed as specific activity mouse IgG (Nordic, Tilburg, The Netherlands) and diami-
in picomoles of labeled PS bound to solid-phase per nobenzidine (DAB) (Sigma Chemical Co.) until develop-
picomole of protein initially dried onto each well per 20 ment of brown foci in the controls. Brown foci were
pmol of input labeled PS. counted with an inverted microscope provided with a
For the blotting experiments, 1000 pmol of peptides in 101 ocular eye grid. Neutralization was expressed by
10 ml was spotted and dried onto an IPVH-20200 Immobi- the formula (number of VHSV N-antigen-positive foci/
lon-P transfer membrane (Millipore, Bedford, MA). The number of VHSV N-antigen-positive foci in control plates
membrane was blocked with 1% defatted milk in phos- containing no antibodies) 1 100. Neutralizing MAb C10
phate/citrate buffer at pH 5.6, washed, and incubated anti-VHSV obtained from Sanofi (Marnes-La-Coquette,
with 10 ml of buffer containing 1500 pmol of PS at 207 France) was used as a positive control.
during 4 hr. After washing and drying, the membrane
was exposed for autoradiography.
Fusion assaySucrose gradient ultracentrifugation of VHSV–
phospholipid complexes
To assay VHSV-induced fusion from within, EPC cells
PS was incubated in the presence or absence of 200 in 96-well plates (about 300,000 cells/well) were infected
mg (100 ml) of purified VHSV at 47 overnight in 1 ml of with 100 ml of cell culture medium containing VHSV 07.71
citrate/phosphate buffer at pH 7.6 or 5.6. Handling, incu- at a multiplicity of infection of 30 and incubated overnight
bation, and ultracentrifugation were carried out at 47 to at 147. On parallel plates, antibodies were serially diluted
minimize possible fusion of PS with the virus (Lenard, in RPMI 1640 cell-culture medium (without bicarbonate)
1993). A sample containing PS (850,000 cpm) was incu- buffered with 20 mM HEPES and 20 mM MES (Sigma
bated with VHSV or 14C-labeled VHSV ([U-14C]aa, Amer- Chemical Co.) to pH 5.6 and incubated overnight at 147.
sham) and applied to the top of a 3-ml discontinuous The next day, the EPC plates were washed and the serial
sucrose gradient (1 ml of 40% sucrose, plus 1 ml of 30% dilutions of antibodies were added onto the EPC wells.
sucrose, plus 1 ml of 20% sucrose). The VHSV was sepa- After 30 min of incubation at 147, the cultures were fixed
rated by ultracentrifugation at 80,000 g during 4 hr at during 10 min with cold methanol, stained with Giemsa,
47 in a Sorvall ultracentrifuge. After centrifugation, the washed, and dried. About 200 nuclei per well were
gradients were collected in 150-ml fractions from the top counted. Percentage of fusion was expressed by the for-
of the tube and assayed for radioactivity.
mula (number of nuclei in syncitia/total number of nuclei)
Anti-p2 binding assay 1 100. At 47 no VHSV-induced fusion from within could
be detected by this assay as reported for VSV (Lenard,Serial dilutions of the viral proteins or peptides dried
onto the polystyrene solid phase were incubated with 0.3 1993).
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3–23) and the putative transmembrane domain (aa 474–
494) might explain why they did not bind PS.
PS binding to solid-phase p2
Examination of the p106 sequence (aa 99 to 113)
showed two arginines (aa 103 and 107) in their carboxy-
terminal part (Table 1). The PS-binding G region (p86,
p96, and p106) showed a computer-predicted a-helix
from aa 82 to 102 contained in a longer hydrophobic aa
(a–d hydrophobic aa) heptad-repeat region from aa 68
to 102. The presence of hydrophobic aa in the a–d posi-
tions of aa heptads would transform an a-helix into an
amphipathic a-helix because of the clustering of the hy-
drophobic aa on one of the helix sides. The presence of
proline at the 86 position would probably make it a bent
a-helix. Therefore, peptide p2 (aa 82 to 109) containingFIG. 1. PS binding to 15-mer overlapping G peptides from VHSV. PS
both the putative amphipathic a-helix and the two argi-(20 pmol per well) binding was at 47, pH 5.6, during 4 hr. About 3000
pmol of peptides per well was used to coat the solid phase, depending nines was synthesized.
on the peptide. The mean and standard deviations from two plates are The p2 showed about a 10-fold higher apparent spe-
represented. cific PS-binding activity than the p106 (the highest PS-
binding peptide of the 15-mer peptide pepscan) (Fig. 2).
The PS binding to solid-phase p2, but not to p4 nor to
RESULTS p3, increased with time and was still slowly increasing
PS binding to 15-mer G peptides
With a peptide load of about 300 pmol per well, a
single peptide (p106, from aa 99 to 113) bound PS about
three times more than the background level. The same
unique peak was observed when the binding reaction
was performed at pH 5.6 or at pH 7.6. No similar peak(s)
could be detected with any of the G 51 peptides when
incubated with labeled PE or PC (not shown).
Using plates coated with 10-fold the amount of pep-
tides (Fig. 1), apparent maximal PS binding was again
obtained with peptide p106 (about eightfold the back-
ground level). The extent of its apparent binding was not
higher because of saturation of its PS binding at 100
pmol/well (Fig. 2). Some peptides with a PS binding
⁄threefold the background were also obtained, like p96,
p206, and p376, and others showed significant PS bind-
ing but gave values £threefold the background, like p16,
p86, p226, p236, p306, and p336. PS binding by immobi-
lon-blotted peptides, estimated by autoradiography, was
positive only for p86, p96, p106 (most intense spot), p206, FIG. 2. Dependence of the PS binding on VHSV peptide, protein, or
purified VHSV concentrations. PS binding (20 pmol/well) to differentp226, p236, p336, and p376 (not shown). The PS binding
amounts of solid-phase peptides was performed at 47, pH 5.6. (l) p2of all the above-mentioned peptides was confirmed when
(aa 82–109), (j) p106 (aa 99–113), (w) p4 (aa 122–151). Results ob-individually tested by solid-phase PS binding in the range
tained with p3 (aa 110–121) and the irrelevant peptides pA and pB
of 100–10000 pmol/well (not shown). The three contigu- were similar to p4. (h) native soluble G from VHSV-infected cell culture
ous overlapping peptides (p86, p96, and p106) show the supernatants purified by affinity chromatography over concanavalin A–
Sepharose (60 kDa), (n) electroeluted purified viral nucleoprotein Nhighest PS-binding activity of the G pepscan (Table 1).
(38 kDa). The results obtained with electroeluted purified viral nucleo-No obvious similarities were apparent among all the
protein Nx (34 kDa), electroeluted viral matrix protein M1 (24 kDa),highest PS-binding peptide sequences, except that they
electroeluted viral matrix protein M2 (20 kDa), and yeast recombinant
contain at least one positively charged aa (p106 contains nucleoprotein N3 (38 kDa) were similar to viral N. (s) purified VHSV.
two and p376 contains three). The absence of charged The averages and standard deviations of duplicates from different ex-
periments are represented.aa in the sequences of the putative signal peptide (aa
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TABLE 1
Position of the p2 Peptide in the G Sequence of VHSV
......FEDINKGLVSVPTRIIHLPLSVTSVSAVASGHYLHRVTYRVTCSTS.....G
PTRIIHLPLSVTSVS p86
VTSVSAVASGHYLHR p96
HYLHRVTYRVTCSTS p106
IIHLPLSVTSVSAVASGHYLH a-helix
IIHLPLSVTSVSAVASGHYLHRVTYRVT
          
65 70 75 80 85 90 95 100 105 110 115
Note. G, partial sequence of the G from VHSV 07.71 (Thiry et al., 1991); p86 and p96, sequence of the 15-mer peptides from the pepscan that
bind PS at the high peptide concentrations (Fig. 1); p106, sequence of the only 15-mer peptide from the pepscan that binds PS at the low peptide
concentrations (Fig.1); a-Helix, predicted by the ANTIGEN program from the PCGene package; p2, designed synthetic peptide containing the a-
helix plus the two-Arg (R)-containing sequence (RVTYRVT). Of the other 15-mer peptides of the pepscan that bound PS at the high peptide
concentrations, only the p376 (369YNRAQYKTMNNTWKS383) was partially inside a–d hydrophobic aa heptad repeats from aa 377 to 398. The
hydrophobic aa of the a–d hydrophobic heptad repeats are in bold. Numbers are the amino-terminal aa positions on the G including the signal
peptide.
after 4 hr of incubation. The kinetics of PS binding to p2 Figure 2 shows that the PS bound as a function of the
concentration of VHSV expressed as its G content waswere identical whether they were performed at pH 5.6
or at pH 7.6 and at 0 or at 207 (not shown). PS binding the highest among all the VHSV proteins or peptides
assayed. All the purified isolates of VHSV tested (F1, F2,to solid-phase p2 performed in the presence of ⁄1000-
fold molar excess of p2 showed background levels of 23.75, 798, 144, 471, 472, and 689) (Basurco and Coll,
1992), including one of infectious hematopoietic necrosisbinding but it was unaffected by the presence of a similar
molar excess of p4 (not shown). The apparent PS binding virus, another fish rhabdovirus (IHNV-Cedar) showed a
similar extent of PS binding to solid-phase virus com-increased with the concentration of p2 bound to the solid-
phase to ⁄100 pmol of p2 per well and then reached pared to VHSV 07.71 (not shown). Maximal apparent PS
binding to solid-phase VHSV nucleocapsids (isolated bya plateau. Only background levels of PS binding were
obtained with p3, with p4, or with the irrelevant peptides banding at 26% sucrose) showed only background levels
in contrast to the PS binding obtained by its correspond-pA or pB (Fig. 2). Similar profiles of the peptide concentra-
tion dependence on PS binding were obtained at pH 5.6 ing purified virions (isolated by banding at 31% sucrose)
(not shown). Treatment of purified virions with eitheror 7.6 (not shown).
PS binding to purified VHSV proteins
TABLE 2
The highest PS binding specific activity was obtained
Apparent Specific Activity of PS Binding to Solid-Phase
with affinity-purified Gs (10-fold higher than with dena- G Peptides, Gs, and VHSV
tured G protein purified from virions, Table 2 and results
VHSV PS bindingnot shown), the only G protein preparation containing
proteins Assay (pmol PS/pmol protein) (n)about 30% of trimers, suggesting that a special conforma-
tion is needed for optimal PS binding. Addition of ⁄1000
p106 Solid phase 0.01 { 0.002 (4)
molar excess of cold PS over labeled PS reduced the p2 Solid phase 0.10 { 0.030 (6)
PS binding of Gs to background levels (not shown). No Gs Solid phase 0.57 { 0.370 (5)
VHSV Solid phase 0.82 { 0.790 (8)significant PS binding could be detected when denatured
VHSV Solution 1.85 { 0.380 (3)nucleoprotein N, M1, or M2, purified from virions, were
used to coat the plates (Fig. 2 and results not shown).
Note. Picomoles of peptide or protein G, as calculated from the initial
picomoles used to coat the solid phase. About 50% of the coated
PS binding to solid-phase VHSV peptides or proteins remained in the wells after the binding assay was
finished, as estimated by measuring the remaining proteins with the
Results obtained from different experiments showed Bradford reagent (Bio-Rad, Richmond, VA). All determinations were
that PS binding to solid-phase VHSV 07.71 was twofold done at pH 5.6, 47, after 4 hr of incubation. Calculations were made in
the lineal range of concentrations. Averages and standard deviationshigher at pH 5.6 than at pH 7.6. Addition of ⁄1000-fold
from n determinations are represented. p106 and p2, peptides from Gmolar excess of cold PS over labeled PS reduced the PS
according to Table 1; Gs, soluble G purified by affinity chromatographybinding of solid-phase VHSV to background levels. The
from VHSV-infected cell supernatants with about 30% of its molecules
PS binding to solid-phase VHSV increased with time of present as trimers; VHSV, whole virus purified by ultracentrifugation.
incubation to reach a saturation value after 2–4 hr. Identi- Picomoles of G in the purified virions was estimated by autoradiography
of PAGE of labeled purified VHSV.cal curves were obtained at 4 and at 207 (not shown).
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observed interaction is most probably due only to PS
binding. Treatment of purified VHSV with trypsin or prote-
ase V8 or with CHAPS abolished its PS-binding activity
(Fig. 3, inset). About 80% of the labeled PS recovered in
the sucrose gradient after ultracentrifugation at pH 5.6
comigrated with VHSV, suggesting that no saturation of
the PS-binding sites of VHSV was obtained. In contrast,
the opposite results (20–30%) were obtained with both
PC or PE, probably as a result of lower affinity and/or
saturation (not shown).
Partial denaturation of the virion after the solid-phase
coating could explain why the amount of PS bound to
solid-phase VHSV at pH 7.6 (50% of the amount bound
at pH 5.6) is higher than the amount of PS bound to
FIG. 3. PS binding to purified VHSV in solution. Purified VHSV (200 liquid-phase VHSV at pH 5.6 (£10% of the amount bound
mg of VHSV containing about 300 pmol of G) and 1000 pmol of labeled
at pH 7.6) (Fig. 3).PS were incubated overnight in 1 ml of buffer at pH 7.6 or 5.6 at 47 to
When the peak of PS radioactivity from gradients con-inhibit fusion. Then they were ultracentrifuged in sucrose discontinuous
gradients (from bottom to top, 1 ml of 40% sucrose / 1 ml of 30% taining PS/VHSV at pH 5.6 (from fractions 2.5 to 3.5 ml)
sucrose / 1 ml of 20% sucrose / 1 ml of PS/VHSV mixtures) either was pooled and ultracentrifuged over a sucrose gradient
at pH 5.6 or at pH 7.6 at 80,000 g for 4 hr. Fractions of 150 ml were at pH 7.6, banding of the radioactivity at 30–34% of su-
collected from the top and samples of 75 ml were counted. The hori-
crose was again obtained (not shown), demonstrating azontal open bar shows the fractions which showed VHSV infectivity.
high stability of the PS associated to VHSV.Thick line, distribution of picomoles of PS in PS/VHSV incubated and
centrifuged at pH 5.6; dotted line, distribution of picomoles of PS in
PS/VHSV incubated and centrifuged at pH 7.6; dashed line, distribution Comparison of apparent specific activity
of 14C counts per minute (cpm) in labeled VHSV incubated and centri- of PS binding
fuged at pH 5.6 (at pH 7.6 results were similar). The inset shows a
similar experiment, thick line, PS/VHSV incubated and centrifuged at Table 2 shows a comparison of the levels of apparent
pH 5.6; dotted line, PS/CHAPS-treated VHSV incubated and centri- PS-binding specific activity expressed as picomoles of
fuged at pH 5.6; dashed line, PS/trypsin-treated VHSV incubated and
PS/picomole of peptides or proteins after several inde-centrifuged at pH 5.6 (results were similar when using protease V8).
pendent measurements of p106, p2, Gs, and VHSV. Thus,Vertical arrow indicates the banding position of catalase (240 kDa)
when centrifuged under the same experimental conditions. while p2 shows a 10-fold increase in PS-binding specific
activity compared to p106, Gs and VHSV show a 5- and
8-fold increase, respectively, compared to p2. Estimates
Tween or Triton to separate the G from the virions also of the PS-binding specific activity of purified VHSV in
reduced the PS-binding capacity of the solid-phase pel- solution show another 2-fold increase, to reach a maxi-
letable material to near background levels (not shown). mal apparent binding of about 1.85 pmol of PS/pmol of
G protein. However, since these measurements were
PS binding to VHSV in solution made at values below saturation of PS binding the above-
mentioned measurements are only valid as relative esti-
Under the conditions employed and from pH 5.6 to
mates.
7.6, in the presence or in the absence of phospholipids,
purified VHSV consistently banded between fractions at Anti-p2 effects on PS binding, viral infectivity, and
31–35% of sucrose in different experiments as deter- virus-induced fusion
mined by ultracentrifugation of purified radioactively la-
beled VHSV. These results were confirmed by VHSV in- To study the possibility of blocking PS binding to VHSV
with anti-p2 antibodies, purified VHSV was first incubatedfectivity assays (representative results are shown in Fig.
3). Under the same conditions and between pH 5.6 and with anti-p2 antibodies at pH 5.6 prior to the addition of
PS. Inhibition of PS-binding to VHSV in solution by previ-7.6, any sonicated labeled phospholipids remained in the
top of the centrifugation tube even after ultracentrifuga- ous incubation of VHSV with anti-p2 varied from 45.4 to
70.3% (Fig. 4).tion for 20 hr (not shown).
However, purified VHSV incubated with labeled PS and To ascertain whether the above-described PS-binding
is really critical to the VHSV life cycle, we conducted aultracentrifuged through a sucrose gradient at pH 5.6
showed comigration of VHSV infectivity and labeled PS. series of experiments to test if p2-specific antibodies
would bind to virions, inhibit viral infectivity, or inhibitIn contrast, at pH 7.6, 90% of the PS remained in the top
of the tube, almost as if there was no VHSV present viral-induced fusion. By using ELISA, we first showed
that anti-p2 antibodies bound to solid-phase VHSV to a(Fig. 3). To minimize possible PS fusion to the VHSV,
the experiments were performed at 47 and hence the greater extent at pH 5.6 than at pH 7.6, suggesting VHSV
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all rabies strains examined; between aa 134 and 161
and 332 and 356 for VSV-NJ; and between aa 134 and
161 and 328 and 369 for VSV-Ind. All these amino-termi-
nal heptad repeat sequences were also followed by a
short 5–7 aa sequence containing at least 1 positively
charged aa (Table 3). Most of the positively charged aa
were R as in VHSV, but K and H were also found in other
rhabdoviruses. The new heptad-repeat regions detected
showed a high degree of sequence conservation among
rhabdoviruses belonging to the same family but were
unrelated when members of different families were com-
pared (Table 3).
DISCUSSION
The main PS binding domain of the G of VHSV has
FIG. 4. Anti-p2 inhibition of PS binding to purified VHSV in solution. been identified using pepscan, synthetic peptides, iso-
Purified VHSV (40 mg containing about 60 pmol of G) and 10 mg of anti- lated G, and purified VHSV solid-phase PS-binding
p2 antibodies were incubated for 1 hr at 207 in 150 ml of buffer at pH
assays. This is the first identification of a phospholipid-5.6. The mixture was then cooled to 47, 150 pmol of labeled PS in 500 ml
binding domain in any rhabdovirus and it also extendsof the same buffer were added, and the mixture was further incubated
at 47 (to minimize possible fusion between PS and VHSV) for 2 hr. the well-known phospholipid interactions of mammalian
Ultracentrifugation of the mixtures was as described. Dotted line, PS; rhabdoviruses (VSV and rabies) to fish rhabdoviruses.
solid line, VHSV/PS; dashed line, VHSV/anti-p2/PS (average and The highest PS-binding peptide (p106, aa 99 to 113)
standard deviations of duplicates are represented). A similar amount
was at the carboxy-terminal part of a predicted a-helixof total labeled PS was recovered (as calculated by addition of the
(aa 82–102) with a–d hydrophobic aa heptad repeatslabel in each fraction) in each of the three cases.
including aa W, H, and T, and a P (aa 86). This was the
main PS-binding region as shown by two other dominant
must undergo a conformational change for the reaction PS-binding peptides overlapping with p106 (p86, aa 79–
to occur (Fig. 5A). Figure 5B shows that anti-p2 antibodies 93, and p96, aa 89–103) (Fig. 1). Its PS binding was
incubated with VHSV at pH 5.6 or at pH 7.6 were unable further confirmed by blotting/autoradiography and by
to neutralize VHSV in contrast to parallel control experi- ELISA of the individual peptides. All these results led to
ments which showed that VHSV was neutralized by com- the design of peptide p2 (Table 1) containing both the
mercial neutralizing MAb C10. region of the heptad repeat with a putative amphipathic
Similar experiments carried out by fusion assays a-helix and a short aa stretch with two arginines (R,
showed that, whereas anti-p2 antibodies were capable 103 and 107). Peptide p2 showed an 10-fold increased
of inhibiting fusion induced by the VHSV infection, anti- specific activity of PS binding compared to p106 (Fig. 2
N MAb 2C9 or unspecific mice IgG1 / IgG2a were not and Table 2). The relevance of PS binding to solid-phase
(Fig. 5C). Furthermore, the pH profile of PS binding by p2 to the possible PS binding to VHSV in solution was
solid-phase VHSV was very similar to the pH profile of suggested by the capacity of a p2-affinity-purified anti-
VHSV induced fusion either from within or from without p2 polyclonal antibody to recognize both p2 and VHSV.
(Fig. 6). The low molar ratio between the bound PS and the solid-
phase p2 suggested that the dehydrated peptides in the
Comparative studies of the p2 sequence with other
solid phase would be unlikely to assume the conforma-
rhabdoviral G sequences
tion present in the native G molecule (Table 2). However,
under carefully controlled experimental conditions, anti-To search for the p2-like region in other rhabdoviruses,
we first defined it as belonging to an amino-terminal part p2 was also capable of inhibiting PS binding to VHSV in
solution (Fig. 4).of the G with⁄three contiguous a–d hydrophobic heptad
repeats containing an hydrophobic aa in position a or d. PS binding to solid-phase p2 was independent of pH
in contrast to PS binding to solid phase VHSV (Coll,Heptad repeats such as those (not necessarily related
to coiled-coil formation) suggesting amphipatic a-helices 1995c). Most probably, pH 5.6 is needed for conforma-
tional changes in VHSV to increase its PS binding bothcould be found in two to three positions in the G molecule
in VHSV as well as in rabies virus and in vesiculoviruses in solid phase and in solution (Fig. 3). Confirming these
data, the reaction of VHSV with anti-p2 by ELISA was(Coll, 1995b). The newly defined heptad repeats were
found between aa 68 and 101, 288 and 319, and 377 and also higher at pH 5.6 than at pH 7.6 (Fig. 5A).
Although the apparent specific activities of the PS400 for VHSV; between aa 99 and 119 and 327 and 359
for IHNV; between aa 140 and 164 and 330 and 360 for binding of p2 (Fig. 2) or of native Gs (Fig. 2) are higher
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FIG. 6. pH dependence of PS binding to solid-phase VHSV and cell
to cell fusion induced by VHSV infection. (l) PS binding to solid-phase
VHSV (equivalent to 6 pmol of G/well) was during 4 hr at different
pHs; (h) fusion from within was after overnight infection of EPC cell
monolayers with 30 plaque forming units (PFU) of VHSV per cell and
incubation during 30 min at 147 at different pHs; (n) fusion from without
was after 1 hr at 47 incubation with 300 PFU of VHSV per cell, washing,
and incubation during 30 min at 147 at different pHs.
than that of p106, they were still lower than the apparent
specific activity of PS binding obtained by purified VHSV
when expressed per picomole of G (Fig. 2 and Table 2).
This difference could be due to the requirement of (a)
other stretch(es) of the G protein sequence for maximal
PS binding (as suggested by the existence of other PS-
binding peptides in the pepscan shown in Fig. 1), (b) an
intact G trimer structure, which could only be present in
the purified virion or in Gs (Gs has a PS binding about
10-fold higher than that of denatured G), (c) collaboration
of other viral proteins (Li et al., 1993; Zakowsky et al.,
1981; Barge et al., 1993), and/or (d) the presence of the
viral membrane or of the viral membrane anchorage of
the G protein. Since a total of three regions of newly
defined a–d hydrophobic heptad repeats do exist in the
G protein of VHSV (Table 3, aa 68–102, aa 288–319, and
aa 377–400) (Coll, 1995b), some of them might be
neutralization/immunoperoxidase assay using 100 plaque forming units
of VHSV. After overnight incubation and fixing, staining of the VHSV
foci was with MAb 2C9 (anti-N), peroxidase-labeled rabbit anti-mouse
IgG, and DAB. Means and standard deviations of duplicated wells are
represented. (C) Inhibition of cell to cell VHSV-induced fusion from
within by anti-p2 antibodies was estimated by first incubating EPC cell
monolayers overnight at 147 with a multiplicity of infection of VHSV of
30. Next day, serial dilutions of antibodies in a pH 5.6 buffer at 147
were added. Fusion was estimated after 30 min at pH 5.6, 147, and
after fixing and staining. The percentage of fused cells in the absence
of antibody controls was 82 { 12. Means and standard deviations from
FIG. 5. Interactions of anti-p2 antibodies and VHSV. (A) Reaction of 3 to 4 wells are represented. A representative result of at least three
anti-p2 with several amounts of solid-phase-purified VHSV (expressed different experiments each is shown in A, B, and C. (l) anti-p2 at pH
as its G content) was estimated by ELISA as indicated. (B) Neutralizing 5.6, (s) anti-p2 at pH 7.6, (h) anti-G MAb C10 at pH 7.6, (n) unspecific
antibodies were estimated by reduction of DAB-positive foci by the mice IgG1 / IgG2a at pH 5.6, (,) anti-N MAb 2C9 at pH 5.6.
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TABLE 3
Amino-terminal Hydrophobic aa (in Bold) Heptad Repeats (Positions abcdefg) of the G of Rhabdoviruses
VHSV 68 FEDINKG LVSVPTR IIHLPLS VTSVSAV ASGHYLH RVTYR 107
VHSVDK 68 FEDINKG LVSVPTK IIHLPLS VTSVSAV ASGHYLH RVTYR 107
IHNGP 99 IHKV LYRTICS TGFFGGQ TIE KALVEMK 126
RABMOK 140 WLRT VTTTKES LLLISPS IVEMDIY GRTLHSP 171
RABPV 140 WLRT VKTTKES LVIISPS VADLDPY DRSLHSR 171
RHRBGD 140 WLRT VKTTKES LVIISPS VADLDPY DRSLHSR 171
RABSAD 140 WLRT VKTTKES LVIISPS VADLDPY DRSLHSR 171
RABHEP 140 WLRT VKTTKES LVIISPS VTDLDPY DKSLHSR 171
RABLEP 140 WLRT VKTTKES LVIISPS VTDLDPY DKSLHSR 171
RABCVS 140 WLRT VRTTKES LIIISPS VTDLDPY DKSLHSR 171
VSVGPN08 134 TVTD AEAHIVT VTPHSVK VDEYTGE WID PHFIGGR 168
VSVGPNJA 134 TVTD AEAHIVT VTPHSVK VDEYTGE WID PHFIGGR 168
VSVGPN29 138 AEAHIIT VTPHSVK VDEYTGE WID PHFLGGR 168
RHGPORS 134 TVTD AEAAIVQ VTPHHVL VDEYTGE WVD SQFINGK 167
RHGM 134 TVTD AEAVIVQ VTPHHVL VDEYTGE WVD SQFINGK 168
RHVSVGR 134 TVTD AEAVIVQ VTPHHVL VDEYTGE WVD SQFINGK 168
Note. The heptads are separated by space. Amino-terminal positions of the first and last aa are numbered by including the signal peptide.
Positively charged aa in the carboxy-terminal position of the heptads are in italics. VHSV (Thiry et al., 1991); VHSVDK (Lorenzen et al., 1993); IHNGP
(Koener et al., 1987); rabies (Tordo et al., 1993); VSVGPN08, VSVGPNJA, and VSVGPN29 (Nichol et al., 1989); RHGPORS (Gallione and Rose, 1985);
RHGM (Rose and Gallione, 1981); and RHVSVGR (Vandepol et al., 1986). IHN, infectious hematopoietic necrosis; RAB, rabies; VSVGPN, vesicular
stomatitis virus, New Jersey; RH, vesicular stomatitis virus, Indiana.
needed for maximal PS binding (for instance, p376, a 15- evidence further implicating this domain would probably
clarify these relationships), these findings are probablymer peptide which is partially inside of one of the heptad
repeats of VHSV, also binds PS) (Fig. 1). relevant to fish rhabdovirus infections. Thus, the whole
sequence of p2 in VHSV 07.71 (Thiry et al., 1991) wasThe p2 peptide (aa 82 to 109) was inside a region of
five a–d hydrophobic aa heptad repeats (aa 68 to 102). completely conserved in the other VHSV sequence re-
ported to date (Lorenzen et al., 1993). Whether or not thisSince the newly defined heptad repeats included hy-
drophobic aa W, H, and T, no coiled coil was predicted conserved domain and/or its nearby regions could be
related to membrane fusion (Chambers et al., 1990) in-in this region by the use of current computer programs
(Cohen and Parry, 1986; Lupas et al., 1991), which only duced by the G of VHSV has not yet been completely
demonstrated. However, similar pH-dependence profilesinclude F, Y, I, L, V, M, and A as hydrophobic aa. Thus,
previous analyses of the VSV G sequence for the pres- were obtained by PS binding to purified VHSV and by
VHSV G-mediated membrane fusion (Fig. 6). Further-ence of a coiled-coil structure also failed to identify any
predicted coiled coil. more, anti-p2 antibodies inhibited the fusion reaction
(Fig. 5C), suggesting the existence of some correlationHowever, because from aa 82 to 102 there is a putative
a-helix with hydrophobic aa heptad repeats, this region between both phenomena.
The preliminary search for p2-like regions (a–d newcould probably adopt the conformation of an amphipathic
a-helix. An amphipathic a-helix followed by two positively hydrophobic aa heptad repeats followed by 2 positively
charged aa) in other rhabdoviruses showed that suchcharged aa (R) could interact with both the fatty acids and
the two negative charges of a PS molecule. Experimental sequences are present in all those studied, although
some variations exist in the number of heptad repeats,evidence (manuscript in preparation) shows that the
physicochemical nature of the PS–p2 bond seems to be in the length of separation of the positively charged aa,
and in the nature of the positively charged aa involved.both hydrophobic (destroyed by detergents) and ionic
(destroyed at pH 12.5, pH at which the charge of the R Whether or not these p2-like regions also bind PS and/
or are involved in membrane fusion is unknown at pres-is about neutral). Hypothetically, the PS binding to solid-
phase p2 could thus be explained by groups of p2 mole- ent, but preliminary experiments have shown that the p2-
like regions of IHNV, rabies virus, and VSV also bind PScules with their hydrophobic sides facing either the solid
phase or the fatty acid chains of the bound PS molecules (unpublished results). The fact that the VSV putative fu-
sion peptide, aa 123–137 (Zhang and Ghosh, 1994) orand their charged sides facing the aqueous solvent inter-
acting with the negative charges of the bound PS. the hydrophobically photolabeled fragment of VSV, aa
58–221 (Gaudin et al., 1995) lie adjacent or around theAlthough it still remains to be determined which stage
of the entry process, binding and/or fusion, requires the putative VSV PS-binding region, aa 134–161 (Table 3),
suggests that they are functionally related. A similar casephospholipid binding domain (for instance, mutagenesis
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1334 from the AIR2 Program of the European Community, SC94-102is found with the putative PS-binding region of the rabies
from the INIA project, Spain, and AGF95-910 from the CICYT, Spain.virus, aa 140–168 (Table 3), which is found inside the
hydrophobically photolabeled fragment aa 102–179
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